Clinical Scorecard: Addressing Hypertension: A Fundamental Aspect of Preventive Cardiology

At a Glance

Key Highlights

• Long-term cumulative systolic BP is linked to increased left ventricular mass, impaired myocardial strain, and myocardial scarring, emphasizing the need for longitudinal BP monitoring.
• Folate deficiency is causally associated with increased hypertension risk, suggesting folate status maintenance as a preventive strategy.
• Intensive systolic BP control (<120 mmHg) reduces cardiovascular events and mortality regardless of worsening renal function, without increased adverse safety outcomes.

Guideline-Based Recommendations

Diagnosis

• Consider cumulative blood pressure exposure over time rather than single-point measurements for cardiovascular risk assessment.
• Use noninvasive digital analysis of brachial pulse waveform to estimate central systolic BP, with a threshold of 135 mmHg for elevated risk identification.

Management

• Implement intensive systolic BP control targeting <120 mmHg to reduce cardiovascular events and mortality, including in patients with worsening renal function.
• Maintain adequate folate status to potentially prevent hypertension development.
• Incorporate flavan-3-ol-rich dietary components (e.g., cocoa, tea, grape extract, apples) as part of hypertension preventive strategies.

Monitoring & Follow-up

• Monitor serum sodium and plasma tonicity levels, as high-normal values are associated with increased hypertension and heart failure risk.
• Track renal function during intensive BP control to assess safety and efficacy.

Risks

• High cumulative systolic BP increases risk of myocardial structural changes and scarring.
• Elevated serum sodium (>140 mmol/L) and plasma tonicity (>287 mOsmol/kg) increase risks of hypertension and heart failure.
• Intensive BP control does not increase safety-related adverse outcomes compared to standard targets.

Patient & Prescribing Data

Adults with or at risk for hypertension, including those with worsening renal function.

Intensive systolic BP lowering to <120 mmHg significantly reduces cardiovascular events and mortality without increasing adverse safety events; folate supplementation and flavan-3-ol-rich diets may offer additional preventive benefits.

Clinical Best Practices

• Assess cumulative blood pressure exposure longitudinally for accurate cardiovascular risk stratification.
• Incorporate folate status evaluation and consider supplementation in hypertension prevention protocols.
• Advocate for dietary intake of flavan-3-ol-rich foods to modestly reduce blood pressure and improve endothelial function.
• Utilize noninvasive central BP measurement techniques to refine cardiovascular risk assessment.
• Apply intensive BP control targets (<120 mmHg systolic) even in patients with worsening renal function to improve outcomes.
• Monitor hydration-related biomarkers such as serum sodium and plasma tonicity as potential early indicators of cardiovascular risk.

References

• Masrouri et al., Cumulative blood pressure exposure and cardiac structure and function: the MESA study
• Zhang et al., Association between folate deficiency and hypertension
• Lagou et al., Impact of flavan-3-ols on blood pressure and endothelial function: meta-analysis
• Wang et al., Diagnostic threshold for central blood pressure in cardiovascular risk assessment
• Yang et al., Risk factors associated with incident hypertension: exposome-wide and genetic analyses
• Xu et al., Intensive systolic blood pressure control in patients with or without worsening renal function
• Rabinowitz et al., Risk of hypertension and heart failure linked to high-normal serum sodium and tonicity